Voluntary cough suppression as an indication of symptom severity in upper respiratory tract infections

The aim of the present study was to determine whether the ability to suppress cough voluntarily is an index of cough severity in upper respiratory tract infection. Cough was measured by means of a microphone linked to a pen recorder and subjects were instructed to voluntarily suppress cough in order to determine cough suppression time. Subjective scores of symptom severity, mood and psychological parameters were made prior to cough measurements. The baseline frequency of cough showed a distribution towards the higher frequencies, with a median of 2.1 (lower quartile 1.2, upper quartile 3.2) coughs.min-1. The results for cough suppression fell into two distinct groups, one group reaching a breaking point within 12.6 min; and another group which did not cough during the 20 min cough suppression period. In the group of subjects which broke from the cough suppression, there was an inverse relationship between the cough suppression time and the baseline frequency of cough. The median frequency of cough following cough suppression was significantly greater than the baseline median frequency of cough. The subjects who reached a breaking point had a greater baseline frequency of cough and a greater symptom severity score, and they also felt more feeble, clumsy, sad and antagonistic than the group which did not reach a breaking point. The subjects who reached a breaking point had significantly greater scores for the psychology parameter of obsessional symptoms than the group which did not reach a breaking point.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. B. Mazzone, L. McLennan, A. E. McGovern, G. F. Egan, and M. J. Farrell Representation of Capsaicin-evoked Urge-to-Cough in the Human Brain Using Functional Magnetic Resonance Imaging Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 327 - 332. [Abstract] [Full Text] [PDF]

				A.E. Vertigan, D.G. Theodoros, P.G. Gibson, and A.L. Winkworth REVIEW SERIES: Chronic cough: Behaviour modification therapies for chronic cough Chronic Respiratory Disease, May 1, 2007; 4(2): 89 - 97. [Abstract] [PDF]

				A H Morice, L McGarvey, I Pavord, and on behalf of the British Thoracic Society Cough Gu Recommendations for the management of cough in adults Thorax, September 1, 2006; 61(suppl_1): i1 - i24. [Full Text] [PDF]

				D. C. Bolser Cough Suppressant and Pharmacologic Protussive Therapy: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 238S - 249S. [Abstract] [Full Text] [PDF]

				P. C. L. Lee, M. S. M. Jawad, J. D. Hull, W. H. L. West, K. Shaw, and R. Eccles The Antitussive Effect of Placebo Treatment on Cough Associated With Acute Upper Respiratory Infection Psychosom Med, March 1, 2005; 67(2): 314 - 317. [Abstract] [Full Text] [PDF]

				S. Hadjikoutis, C.M. Wiles, and R. Eccles Cough in motor neuron disease: a review of mechanisms QJM, September 1, 1999; 92(9): 487 - 494. [Full Text] [PDF]